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The germinal center (GC) is a specialized microstructure that forms in secondary
lymphoid tissues, producing long-lived antibody secreting plasma cells and memory B
cells, which can provide protection against reinfection. Within the GC, B cells undergo
somatic mutation of the genes encoding their B cell receptors which, following successful
selection, can lead to the emergence of B cell clones that bind antigen with high affinity.
However, this mutation process can also be dangerous, as it can create autoreactive
clones that can cause autoimmunity. Because of this, regulation of GC reactions is
critical to ensure high affinity antibody production and to enforce self-tolerance by
avoiding emergence of autoreactive B cell clones. A productive GC response requires
the collaboration of multiple cell types. The stromal cell network orchestrates GC cell
dynamics by controlling antigen delivery and cell trafficking. T follicular helper (Tfh) cells
provide specialized help to GC B cells through cognate T-B cell interactions while Foxp3+
T follicular regulatory (Tfr) cells are key mediators of GC regulation. However, regulation
of GC responses is not a simple outcome of Tfh/Tfr balance, but also involves the
contribution of other cell types to modulate the GC microenvironment and to avoid
autoimmunity. Thus, the regulation of the GC is complex, and occurs at multiple levels.
In this review we outline recent developments in the biology of cell subsets involved in
the regulation of GC reactions, in both secondary lymphoid tissues, and Peyer’s patches
(PPs). We discuss the mechanisms which enable the generation of potent protective
humoral immunity whilst GC-derived autoimmunity is avoided.
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Interactions between T and B cells are critical for the development of most humoral immune
responses; these can be protective in response to vaccination or infection, or deleterious, when
driving autoimmunity, allergy, or transplant rejection. Long-lived T-dependent humoral immunity
is derived from specialized microanatomical structures known as germinal centers (GCs), that
form in secondary lymphoid organs, such as the spleen and lymph nodes, upon infection, or
immunization with a T-cell dependent antigen (Figure 1) (1). Ectopic GCs can also appear in non-
lymphoid tissue in multiple inflammatory states including autoimmune disease, cancer, and during
infection (2). Within GCs, B cells undergo somatic hypermutation (SHM) of the genes encoding
their B cell receptor (BCR). Because this mutational process is random, mutated B cells require
selection to ensure that only B cells bearing a BCRwith an improved affinity for antigen differentiate
into long-lived antibody secreting plasma cells and memory B cells (3). Therefore, tight regulation
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of GCs is critical to ensure that a potent immune response
against foreign antigen can occur without cross reactivity against
self-antigens.
For B cells to participate in the GC response, they first need
to recognize their cognate antigen via their BCR. B cells are able
to directly bind soluble antigen or bind antigen presented on
the surface of follicular dendritic cells (FDCs), macrophages or
dendritic cells (4–7). Once activated by antigen encounter, B cells
upregulate the chemokine receptor CCR7, which facilitates the
migration of B cells via a chemokine gradient toward the CCR7
ligands CCL19 and CCL21 expressed in the T cell zone (8). At
the interface between the B cell follicle and the T cell zone (T:B
border), B cells present fragments of peptide antigen on major
histocompatibility complex (MHC)-Class II to CD4+ helper T
cells that provide them with survival and co-stimulatory signals
(8, 9). B cells will then divide at the perimeter of the follicle
and will either initiate the GC response or differentiate into
short-lived extrafollicular plasma cells ormemory B cells (10–12).
Extrafollicular plasma cells produce the first wave of antibodies
before undergoing apoptosis within a few days, providing an
initial burst of antibodies that are essential for early control of
infection while the GC response is established (13).
After cognate interactions with CD4+ T cells, activated B
cells will migrate to the center of the follicle to seed the GC
response (14). These GC B cell precursors begin to rapidly divide
and undergo clonal expansion during which the GC is divided
into two distinct compartments known as the dark zone (DZ)
and the light zone (LZ; Figure 1) (15). The DZ contains the
rapidly diving B cells known as centroblasts, which undergo SHM
(16–18). Centroblasts express the chemokine receptor CXCR4
whose ligand, CXCL12, is produced by stromal cells in the
DZ (CXCL12-expressing reticular cells, CRCs). This chemokine
localizes the centroblasts within the DZ, thereby generating GC
polarity (16, 19). Once GC B cells have undergone SHM in the
DZ, they downregulate CXCR4 and migrate to the LZ, to receive
positive selection signals. The LZ is rich in FDCs that produce
CXCL13, which attracts GCB cells that exit theDZ as centrocytes,
through their expression of CXCR5 (15, 17, 18). The LZ also
contains Tfh and Tfr cells that are important for the successful
and regulated continuation of the GC response (3). FDCs and Tfh
cells are critical for the positive selection of centrocytes, while Tfr
cells are thought to regulate the output of the GC response (3).
Together, these processes culminate in the emergence of long-
lived antibody secreting plasma cells and memory B cells whose
BCRs bind antigen with high affinity. These effector cells are able
to provide protection against subsequent infection, in some cases
providing life-long immunity against particular pathogens.
DC-INITIATED TFH CELL DEVELOPMENT
IS ESSENTIAL FOR THE GC RESPONSE
Tfh cells are unique in their ability to support GC reactions.
Tfh differentiation is a multistage process (20). First, naïve
CD4+ T cells are primed by dendritic cells (DCs). During
these interactions, T cells require two signals to be activated:
first binding of the T cell receptor (TCR) to peptide:MHC and
secondly, a co-stimulatory signal through ligation of the receptor
CD28 by its ligands CD80/86 which are expressed on the surface
of DCs. During this T:DC interaction, T cells also integrate
signals from multiple cytokines that skew their differentiation
toward a Tfh cell fate. Here, Tfh cell precursors (pre-Tfh cells)
upregulate Bcl6 and CXCR5, and downregulate CCR7, leading to
migration of activated T cells toward the T:B border. Here, SAP-
dependent interactions with activated B cells enable full Tfh cell
differentiation.
It is now clear that specific subsets of DCs can support
the initial steps of Tfh differentiation (21). Although it appears
that this is not a “one DC fits all responses” rule as different
types of immune stimuli trigger different DC populations to
support Tfh cell differentiation. Adjuvants that trigger Toll-
like receptor (TLR)-9 enable monocyte derived DCs to induce
Tfh differentiation (22). In Th2 skewed responses, CD8a−
conventional dendritic cells (cDCs) are capable of inducing Tfh
cell differentiation through higher expression of ICOSL and
OX40L co-stimulatory signals compared to CD8a+ DCs in both
mice and humans (23, 24). Similarly, CD11b+ cDC (cDC2,
which are CD8a−) cells are both necessary and sufficient for Tfh
induction following intranasal immunization (25). These cDC2
have a phenotype consistent with location at the T:B border.
In contrast, CD301b+ DCs are thought to limit effective Tfh
differentiation and antibody responses following immunization
with type 2 adjuvants (26), through expression of the inhibitory
costimulatory ligand PD-L1 (26). Taken together, priming of
naïve CD4+ T cells by DCs is essential for the first step in Tfh
cell differentiation, but multiple DC types are capable of doing
the job.
REGULATION OF THE GC RESPONSE BY
CHEMOKINES AND THE STROMAL CELL
NETWORK
Chemokines and Immune Cell Migration
The chemokine system coordinates the migration and
positioning of immune cells within secondary lymphoid
organs (27). Chemokines are typically secreted chemotactic
cytokines that constitute a family of more than 40 small proteins
with a molecular weight of 7–12 kDa (28). Chemokines are
able to mediate the migration and positioning of immune cells
by engaging G protein-coupled receptors (GPCRs), expressed
on the surface of all immune cells, with high affinity (29).
Various lymphoid and non-lymphoid cells are able to express
chemokines (29), however the expression of chemokines by
mesenchymal stromal cells is critical for guiding lymphocytes
and dendritic cells (DCs) to secondary lymphoid organs (SLOs)
during the initiation of the immune response (27). Within
the SLOs, different types of stromal cells play specific roles to
facilitate the localization of hematopoietic cells (Figure 2). In
the T cell zone, fibroblastic reticular cells (FRCs) orchestrate the
migration, localization and survival of DCs, T cells and B cells by
producing CCL19, CCL21, and CXCL12 (30–32). The CCL19/21
produced by FRCs enables localization of both CD4+ T cells and
DCs to the T cell zone, via CCR7-mediated migration, bringing
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FIGURE 1 | The germinal center (GC) response. The GC is a specialized microenvironment formed within the B cell follicles of secondary lymphoid tissues upon
infection or immunization. The GC is divided into two distinct compartments. The dark zone (DZ) that contains a network of CXCL12-producing reticular cells (CRCs)
and is the site of GC B cell proliferation and somatic hypermutation (SHM). Centroblasts then follow a CXCL13 gradient to enter the light zone (LZ) as centrocytes
through their expression of CXCR5. In the LZ, centrocytes capture antigen presented on follicular dendritic cells (FDCs) which they internalize, process and
subsequently present to T follicular helper (Tfh) cells in order to undergo selection. This process is regulated by T follicular regulatory (Tfr) cells which are also present in
the LZ. Upon receiving survival signals from Tfh cells, centrocytes re-enter the DZ for further rounds of proliferation and SHM after which they exit the GC as memory B
cells or high-affinity antibody-secreting plasma cells.
these rare cells together to facilitate T cell priming and activation
(33–35). In the B cell follicles there are two types of stromal
cells: follicular dendritic cells (FDCs) that produce CXCL13
and CXCL12-producing reticular cells (CRCs) which promote
the localization of B cells during the germinal center response
(19, 36, 37). FRCs at the boundary of the T cell zone and follicle
produce B cell-activating factor (BAFF) to maintain the primary
follicle structure (30). Antigen encounter by naïve B cells is
facilitated by CXCR5-mediated migration toward the CXCL13-
rich follicles (38–40). This localizes them close to the subcapsular
sinus (SCS) where small soluble antigens are drained and can
directly trigger B cell activation (38–40). Alternatively, antigens
drained through the SCS can be captured by follicular FDCs
which typically recognize antigen bound by antibody and/or
complement, known as immune complexes (ICs) (41). FDCs
are able to retain antigen on their surface for prolonged periods
of time, allowing B cells to scan the follicular FDC network for
cognate antigen to trigger activation (42). In addition, the SCS
facilitates the movement of lymph fluid and is lined by marginal
reticular cells (MRCs), which are FDC precursors and provide
structural support (43). The distribution of these stromal cells in
specific areas of the SLOs facilitates the continuous circulation
and subsequent activation of lymphocytes that enter the LNs
and Peyer’s patches (PPs) through high endothelial venules
(HEV) (44). Together, the stromal cell network provides the
structural and chemotactic support required for GC initiation
and maintenance.
Stromal Cells and Chemokine Gradients
Regulate GC Initiation
The initiation of the GC requires both CD4+ T cells and B cells
to be activated by cognate antigen. The initial encounter and
activation of lymphocytes by antigen is facilitated by stromal
cell networks, as described above. Once both CD4+ T cells and
B cells are activated by antigen, they must migrate toward the
T:B interface to undergo cognate interactions that ultimately
lead to GC formation (27). Activated CD4+ T cells begin to
downregulate CCR7 and upregulate CXCR5 which allows them
tomove away from the CCL19/21-rich T cell zone and toward the
interfollicular region (45–47). Simultaneously, activated B cells
upregulate CCR7 while maintaining CXCR5 expression which
allows them to move toward the edge of the follicle at the T:B
interface (48). Additionally, both cell types upregulate Epstein-
Barr virus-induced G protein coupled receptor 2 (EBI2) which
facilitates their localization at the T:B border (49–51). Stromal
cells at the inner- and outer-follicle regions regulate the oxysterol
ligands for EBI2 which facilitates the co-localization of EBI2+ T
and B cells enabling cognate T:B interactions (8, 51–54).
The final step for GC formation requires activated CD4+ T
cells and B cells to migrate to the follicle from the T:B border
as GC B cells and fully differentiated Tfh cells. Both CD4+ T cells
and B cells downregulate CCR7 and EBI2 whilst stably expressing
CXCR5. This enables them to escape the chemotactic pull of the T
cell zone and outer follicle in order to move into the center of the
follicle (14, 51, 55, 56). Both CD4+ T and B cells upregulate S1P
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FIGURE 2 | Lymph node structure is supported by stromal cells. Secondary lymphoid organs are divided into distinct regions through the generation of chemokine
gradients by stromal cells. In the lymph node (LN), these chemokine gradients allow the circulation of lymphocytes which enter through high endothelial venules (HEV).
In the T cell zone, fibroblastic reticular cells (FRCs) generate a CCL19 and CCL21 gradient which facilitates the migration of T cells and dendritic cells (DCs). The B cell
follicles contain follicular dendritic cells (FDCs) which generate a CXCL13 gradient that promote the localization of B cells. Upon infection or immunization, antigen can
enter the LN through the subcapsular sinus (SCS) or can be brought by DCs to trigger the activation of lymphocytes.
receptor 2 (S1PR2) that supports their localization to the follicle
center by binding S1P, which is present in low concentrations
within the follicle, and reduces their responsiveness to other
chemoattractants (57, 58). Loss of S1PR2 results in B cells losing
their ability to accurately localize at the center of the follicle
and the combined loss of S1PR2 and CXCR5 abrogates T cell
localization to the GC (57, 58). At the center of the follicle,
signals exchanged between T and B cells provide the final cues
for Tfh cell differentiation and promote B cell proliferation to
seed the GC (59). Once the GC response is initiated, both the
FDC and CRC networks expand and divide the GC into the two
distinct light and dark zones. Both the CRC and FDC networks
are essential in maintaining the function and structure of the GC
while orchestrating the interactions between different immune
cells of the GC.
The Role of Follicular Stromal Cells in the
Regulation of the GC Response
The network of CRCs was recently discovered due to their high
expression of CXCL12 in the DZ and they were found to have low
network density as well as a net-like morphology (19, 37). These
cells are distinct from FDCs and FRCs as they do not express the
typical FDC/FRC markers which include CD35, ERTR7, FDC-
M1/M2, FcγRII, and VCAM1 (37). Due to the lack of antigen-
capture mediators such as CD35 and FcγRII on the surface of
CRCs, it is likely that CRCs do not function as antigen presenting
cells but meet another specialized requirement in the DZ niche.
Thus, CXCL12 production is believed to be one of the essential
functions of CRCs in the GC DZ (27). Moreover, two-photon
laser-scanning microscopy revealed that GC B cells are able to
crawl in and around CRC networks, which depend on CXCR4
signaling for their distribution (37). Therefore, CRCs likely
provide support for GC B cells through structural maintenance
of the DZ in addition to generating a CXCL12 gradient within
the GC. However, the precise role of CRCs in the GC remains to
be fully elucidated.
In contrast to the CRCs, FDCs were discovered in the
1960s and are better characterized. During GC formation,
the expansion of FDCs is mainly thought to be driven by
proliferation of MRCs and their subsequent differentiation into
FDCs (60). Throughout this process the FDCs also become
activated through TLR4 (61, 62) and B-cell derived lymphotoxin
(LT) α1β2 signaling (63), though the precise mechanisms
remain unidentified. Once activated, FDCs begin to increase
their expression of CXCL13 and BAFF, which support GC
development and maintenance of the LZ (27). Studies in mice
have shown that ablation of FDCs results in GC termination
due to reduced survival and localization of GC B cells; therefore
FDCs are absolutely necessary for the GC response (64). The
activation of FDCs also triggers an increase in their expression
of antigen-capture molecules such as CD35, CD21, and FcγRII
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(27). These molecules are critical for the long-term retention
and display of antigen on the surface of the FDC network.
This allows antigen-specific B cells to test their Ig receptors by
capturing antigen from FDCs to subsequently internalize, process
and present the antigen peptides to Tfh cells in order to receive
critical survival signals (17, 42). FDCs can also produce cytokines
such as IL-6 (65, 66) and IL-15 (67, 68) that promote SHM and
IgG production and support B cell proliferation, respectively.
Additionally, FDC production of FDC-M1 aids in the clearance
of apoptotic GC B cells as FDC-M1 coats B cells, marking them
for clearance by tangible-body macrophages (69).
Stromal Cells Regulate Tfh and GC B Cell
Interactions Within the GC
The CRC and FDC networks form distinct niches critical for
the structural support and maintenance of the GC. These two
stromal cell subsets are also crucial for the localization of GC B
cells within the GC and form a spatially segregated stage where
T and B cells can undergo crucial interactions to promote the
generation of high-affinity antibody-secreting plasma cells and
memory B cells. During the GC response, GC B cells shuttle
between the DZ and LZ using a timed program (19). GC B
cells can localize in the DZ through their expression of CXCR4
in response to CXCL12 (16). However as they proliferate they
downregulate CXCR4 and upregulate CXCR5, which together
with the FDC-mediated CXCL13 gradient, enables them to move
toward the LZ (16, 19). Migration to the LZ is necessary for
centrocytes to acquire antigen and present it to Tfh cells in
order for high-affinity B cell clones to survive (3). Through
signals received in the LZ, a subset of centrocytes is then able
to re-express CXCR4 and migrate back to the DZ via CXCL12-
mediated migration where they can undergo further rounds of
proliferation and SHM (19). This results in bidirectional B cell
trafficking between the two zones that allows for multiple rounds
of proliferation and selection to further refine the affinity of
responding GC B cells (17, 19).
Tfh cells are conventionally thought to localize to the LZ
through their high-expression of CXCR5. For Tfh cells to be
retained in the GC they must express not only S1PR2, but
also SLAM-associated protein (SAP), which promotes antigen-
specific T-B adhesion (70, 71). SAP-deficient T cells are able to
localize to the follicle through their expression of CXCR5, but
once in the follicle they exhibit severe defects in GC recruitment
and retention (71). Additionally, GC retention of Tfh cells
can be mediated by expression of a class B Ephrin, EFNB1,
which negatively controls Tfh cell retention and also promotes
interleukin (IL-21) production (72). While these studies have
investigated mechanisms by which Tfh cells are retained within
the GC, the functional importance of their localization within the
GC compartments remains largely unexplored. GC Tfh cells are
able to co-express both CXCR4 and CXCR5 (73). The expression
of CXCR4 by Tfh cells has been shown to determine their
localization between the LZ and DZ (73). Moreover, in vitro
studies with human immune cells isolated from tonsils have
shown FDCs may play a role in modulating CXCR4 expression
on T cells (74). Another study also showed that Tfh cells
which express IL-21 have high expression of CXCR4 and are
able to localize closer to the DZ (75). However, the functional
significance of differential CXCR4 expression of Tfh cells and
their localization within the GC remains unknown largely due to
the importance of CXCR4 in thymic maturation of T cells (76).
Thus, GC stromal cells also play a role in directing the localization
of Tfh cells.
Chemokine secretion by the stromal cell networks of SLOs
is essential for the regulation of various aspects of the immune
system, ranging from the homeostatic migration of lymphocytes
to the initiation and maintenance of the GC response. Within the
GC reaction, stromal cells provide chemokine cues that promote
B cell trafficking between the different GC compartments as well
as supplying antigen crucial for affinity maturation. However,
whether the different stromal cell subsets of the GC can regulate
the function of Tfh cells remains to be explored. Further study
into the mechanisms by which stromal cells can regulate the GC
will lead to a better understanding of the events required for
optimal GC responses against infection and vaccination.
REGULATION OF GC RESPONSES BY T
FOLLICULAR REGULATORY CELLS
While the specialized formation of the GC and T—B cell
crosstalk are critical to provide protection against a broad
range of invading pathogens, the stochastic nature of SHM
makes the generation of cross-/self-reactive B cell clones a
by-product of GC responses to foreign antigens (77). This
can lead to the development of autoimmune disease. The
importance of Treg cells for the control of both autoimmune
and antibody responses has been long known (78–81). Mice
and humans with loss-of-function mutations in the Foxp3
gene do not form Treg cells and suffer from a fatal early-
onset T cell-dependent, lymphoproliferative disorder manifested
by autoantibody-mediated autoimmunity (diabetes, thyroiditis,
haemolytic anemia) and increased levels of circulating antibodies
(82–86). The link between antibody production and Treg cells
lead researchers to identify a subset of Treg cells that gain access
to the B cell follicle and participate in the regulation of the
GC response (87–89). These T follicular regulatory (Tfr) cells
simultaneously express markers of Treg and Tfh cells and have
suppressive function (87–91). Since their discovery, Tfr cells have
been regarded as putative key GC regulators that fine tune the
response.
Tfr Cell Differentiation
Tfr cells are derived from Foxp3+ precursors; the majority come
from thymic Treg cells, but they can also arise from naïve T cells
when immunization conditions favor induced Treg development
(92, 93). The differentiation of Tfr cells is not characterized as
well as the differentiation of Tfh cells, but it appears that they
also undergo a multistep Bcl-6-dependent differentiation process
like Tfh cells. Like other naïve CD4+ T cells, antigen presentation
by DCs is required for Tfr cell differentiation (88, 92, 94, 95),
along with positive co-stimulatory signals through CD28 and
ICOS (59, 96–101). However, the DC subsets directly responsible
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for stimulating Tfr cell differentiation remain unclear. The
differentiation into GC Tfr cells is also dependent on B-cell
interactions (88, 94). However, B cells appear to be required only
for final stages of Tfr cell differentiation, as putative Tfr cells were
found in the blood of µMT mice following immunization and
B-cell deficiency patients (BTK deficiency) (94, 102).
Despite some similarities, there are also differences in the
differentiation requirements of Tfr and Tfh cells. The negative
co-stimulatory molecules PD-1 and CTLA-4 impact Tfr cell
generation. PD-1 signaling selectively inhibits thymic Treg cell
differentiation into Tfr cells, prior to B-cell interactions in
a PD-L1-dependent manner (100), while blockade of PD-L1
signals in the periphery inhibits the generation of induced
Tfr cells (92). Deletion of CTLA-4 leads to an increase in
the frequency and absolute numbers of Tfr cells (103, 104).
However, it is still unknown whether CTLA-4 impairs Tfr cell
differentiation or maintenance, or whether the increased Tfr
cell numbers are simply due to an increased GC response
overall. IL-21 is a key helper cytokine produced by Tfh
cells, which has a negative impact on Tfr cell numbers (105,
106), suggesting that Tfh cells evoke a feedback mechanism
to control Tfr cell numbers via this cytokine (107, 108).
Mechanistically, Jandl and colleagues propose that IL-21 induces
Bcl-6 expression which in turn limits CD25, and the reduction
of CD25 expression then leads to lower responsiveness to IL-
2, consequently restraining Tfr cell expansion (105). However,
because it has been shown that Tfr cells do not express CD25,
the high affinity IL-2 receptor(109–111), it is more likely
that IL-21 would limit Tfr cell precursors, rather than fully
differentiated Tfr cells. CD25 expression limits Tfr differentiation
through induction of Blimp-1 (109), a transcription factor
known to repress Tfr differentiation (88). Although, IL-2 seems
to inhibit Tfr cell differentiation, the absence of IL-2/STAT5
signaling may lead to Foxp3 downregulation (112). Therefore,
the maintenance of Foxp3-expressing Treg cells in the absence of
IL-2/CD25 (IL-2Rα) must be accomplished by other homeostatic
mechanisms, such as high amounts of intermediate-affinity
IL-2 receptor (CD122/IL-2Rβ), which may be sufficient to
prevent Foxp3 downregulation (109). Whether CD25+ and
CD25− Tfr cells represent two stages of differentiation or
two functionally and biologically distinct cell subsets is still
unknown.
Tfr cell differentiation culminates in the expression of Bcl-6,
the master transcriptional regulator for Tfr cell differentiation
(87–89). However, it is not the only transcription factor that
contributes to the Tfr cell fate. Expression of transcription
factor nuclear factor of activated T cells 2 (NFAT2, also
known as NFATc1) is required for CXCR5 upregulation on
Treg cells through binding to the Cxcr5 promoter (113).
Tfr cell differentiation also requires an intricate network of
many other molecules, such as stromal interaction molecule 1
(STIM1) and STIM2 (114, 115), tumor necrosis factor receptor
(TNFR)-associated factor 3 (TRAF3) (116), signal transducer and
activator 3 (STAT3) (117), p85α-osteopontin, and members of
the helix-loop-helix family (E and Id proteins). More recently,
mTORC1 signaling was also shown to induce de novo Tfr cell
differentiation from thymic-derived Treg cells (118).
Identity and Specificity of Tfr Cells
The first studies describing Tfr cells reported that these cells are
derived from thymic Treg cells (87–89). Recent evidence further
supports the preferential origin of Tfr cells from thymic Foxp3+
Treg cells (93), but Tfr cells can also be derived from induced
Treg cells, that arise from the induction of Foxp3 expression in
naïve CD4+ T cells (92). Tfr cell recruitment into the GC and
their suppressive capacity occurs in response to immunization,
but Tfr cells do not need to be specific for the immunizing antigen
(93, 94). However, a proportion of Tfr cells can also be specific
for the immunizing antigen (92), suggesting that Tfr cells can
arise though a number of pathways. TCR repertoire analysis
at the population level showed that Tfr cells are an oligoclonal
population and have a TCR repertoire that is more similar to the
repertoire of Treg cells than Tfh cells (93, 119). How Tfr cells are
recruited to the GC upon immunization, with TCR specificities
that are irrelevant to the immunizing antigen, is a significant
unknown in the biology of these cells.
One remaining question regarding the regulation of humoral
immunity is the overall contribution of extrafollicular responses
to the generation of B cell autoreactivity and its regulation. It is
not clear to which extent extrafollicular sites contribute to the
emergence of autoreactivity in many diseases, and it remains
unknown whether specialized regulatory mechanisms are in
place at those locations.
Mechanisms of Tfr Cell Function
Tfr cells specialize in the regulation of the GC response by
directly modulating Tfh cell proliferation, B cell metabolism and
cytokines secreted by Tfh cells in secondary lymphoid organs.
Thus, Tfr cells modify GC outcomes at several levels: (a) control
of GC size; (b) selection of antigen specific Tfh and B cell clones;
and (c) modulation of class switch and affinity maturation of
antibodies (Figure 3).
The precise molecules that underpin such effects are
largely unknown, but undoubtedly encompass CTLA-4-mediated
suppression (103, 104). CTLA-4 has a widely known function
in maintaining immune homeostasis and mediating Treg cell
function (81, 120–122). Mice that lack CTLA-4 on Treg cells have
spontaneous GC responses (104), however in these experiments
the caveat is that CTLA4 is lost on all Treg cells, not only Tfr
cells. Tamoxifen-induced CTLA-4 depletion on Treg cells at the
time of immune challenge led to an expansion of GC B, Tfr,
and Tfh cells due to defective Treg cell function (103). Whether
CTLA-4 mediated CD80/CD86 transendocytosis plays a role in
Tfr cell function within GCs is still controversial (103, 104).
Despite the described role of CTLA-4 in mediating Tfr cell
function, it is expected that these cells employ multiple and
complementary regulatory mechanisms such as TGF-β, IL-10
(88, 94) and granzyme B secretion (88, 123) (Figure 3) to perform
their suppressive functions.
The suppressive functions of Tfr cells seem to act directly on
the metabolic pathways of B and Tfh cells (94, 100, 103, 106).
Using several in vitro systems, it was shown that Tfr do not affect
the transcriptomic signature or activation potential of B cells or
Tfh cells, however these cells lose the ability to express key effector
molecules, such as Pou2af1, Xbp1 and Aicda, in the presence of
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FIGURE 3 | Mechanisms of Tfr cell-mediated regulation of humoral responses.
Tfr cells regulate T – B interactions within the germinal center (GC) by physical
interference at the immunological synapse, which is required for the survival
feedback loop between GC B cells and T follicular helper (Tfh) cells. CTLA-4 is
a key molecule of T follicular regulatory (Tfr) cell function at immunological
synapse, as it directly blocks CD80/CD86 co-stimulatory signals. Using these
mechanisms, Tfr cells impair GC B cell metabolism (mainly by decreasing
glucose uptake and usage) and induce the downregulation of GC B cell
effector molecules, such as Pou2af1 (required for GC B cell formation), Xbp1
(required for antibody secretion), and Aicda (required for class switch
recombination). On the other side of the immunological synapse, Tfr cells limit
IL-21, and IL-4 secretion by Tfh cells. Granzyme B, IL-10 and TGF-β secretion
by Tfr cells may also account for their regulatory capacity.
Tfr cells (106). It appears that Tfr cell-imposed B cell modulation
persists in the absence of Tfr cells due to epigenetic changes.
However, IL-21 was able to overcome the suppressive effect of
Tfr cells by both increasing B cell metabolism and inhibiting Tfr
cells (106).
While initial studies ascribed the control of GC size, class-
switching and antibody affinity to Tfr cells (87–89, 124), more
recent studies support the concept that Tfr cells can restrain
the generation of antigen-specific antibodies while favoring the
emergence of high affinity antibody-secreting B cells (103, 104,
109, 124, 125). Indeed, CTLA-4 competent Tfr cells seem to
impose more stringent B cell competition for Tfh cell help
(103, 104). Additionally, the outcome of the GC reaction can
also be correlated with age-induced alterations in Tfh and Tfr
cell numbers and function (126). In aged mice, reduced titers
of NP-specific antibodies following NP-OVA immunization were
associated with defective Tfh cell function and higher proportions
of highly suppressive Tfr cells (126).
These regulatory mechanisms have been further studied in
murine models of autoimmune disease, where Tfr cells were
directly implicated in ensuring tolerance to self-antigens and
preventing autoimmunity (109, 113, 115, 127). Thus, the selective
use of Tfr cells (or IL-2 to fine-tune Tfr cell responses) might
be a novel way to therapeutically intervene in diseases where
pathogenic GC reactions are the cause of underlying pathology.
Taken together, it appears that cognate interactions are
required for Tfr-mediated regulation, while the specific nature
of the cellular interactions are yet to be fully characterized.
Results from in vitro experimental systems devoid of any antigen-
presenting cells besides B cells suggest that B-Tfr interactions
can trigger regulation that is sufficient to overcome the positive
signals delivered by co-cultured Tfh cells (106).
Division of Labor Between Treg and Tfr
Cells
Although we have a good understanding of broad Treg cell
biology, it is still unclear how different Treg cell subsets integrate
to underpin immune tolerance and regulation of humoral
responses. It is clear that the absence of Foxp3+ Treg cells leads
to uncontrolled and spontaneous humoral responses (128–131),
however, the contribution of CXCR5+ Tfr cells to this overall
pathology is not known. Nevertheless, humoral suppressive
capacity has been assigned preferentially to Tfr cells. This concept
arose from observations where conventional (non-Tfr) Treg cells
lacked the capacity to suppress Tfh cell proliferation, B cell
activation, and class switch recombination (94, 106). Conversely,
two independent groups found a comparable decrease in Tfh
cell proliferation when co-cultured with Tfr and conventional
Treg cells (87, 104). Hence, while a direct comparison of Tfr and
conventional Treg cells in physiological conditions is lacking,
Tfr cells presumably acquire their unique humoral suppressive
capacity when they co-opt the Tfh cell differentiation program.
The suppression of Tfh cell proliferation is probably not unique
to Tfr cells, as it might be a general Treg cell feature. However,
one critical aspect that might distinguish Tfr from conventional
Treg cells in vivo is the exceptional ability of Tfr cells to access the
GC.
Blood and Human Tfr Cells
GC reactions are orchestrated in secondary lymphoid organs,
but in the blood of mice circulating Tfr cells-like cells have also
been described (94). This adds an additional layer of complexity,
as different immune compartments might evoke different Tfr
cell responses (94, 100, 132–135). The population of circulating
ICOSlo Tfr cells were shown to behave as memory cells and
have less suppressive capacity. They originate after priming by
DCs, but without full commitment to the GC fate (94, 100).
This suggests that Tfr cell effector activity is initiated during
contact with DCs in the T cell zone, strengthened in the inter-
follicular region during contact with B cells, and optimized in
the GC. However, it is not clear where exactly Tfr cells modulate
GC reactions, especially in humans. Recently, human Tfr cells
were found to be preferentially distributed at the periphery of
GCs (136). While the same has also been shown in murine
models (100), it is still unknown whether human Tfr cells share
all the biological features of murine Tfr cells. For instance, in
human lymph nodes, Tfr cells are not PD-1+CD25− like in mice
(100, 109, 136).
Although a CD69− human tonsil Treg cell subset with B cell
suppressive function was discovered before the identification of
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Bcl-6+Foxp3+ Tfr cells in mice (137, 138), the restricted access
to human secondary lymphoid tissues forced the search for
putative Tfr cells in human blood. Several studies have focused
on circulating CXCR5+Foxp3+ T cells to define Tfr cells in
humans with different diseases (90). We recently established
the biology and ontogeny of human blood CXCR5+Foxp3+ Tfr
cells (102). Human blood CXCR5+Foxp3+ Tfr cells comprise
Tfr cell precursors arising from secondary lymphoid tissues
prior to B-cell interactions. Thus, human blood Tfr cells are
predominantly CD45RO− naïve cells not yet endowed with
full B cell and humoral regulatory functions. Furthermore,
autoimmune diseases may be associated with different types of
dysregulation of the GC response. Therefore, it is likely that
different alterations of Tfr frequency, distribution, and function
will be found in different autoimmune diseases.
Peyer’s Patches: Specialized Germinal
Centers in a Unique Anatomical Location
GCs in Peyer’s patches (PPs) are unique due to their special
anatomical location and functions. They are influenced by the
gut microbiota, and in return produce IgA antibodies which
contribute to the control of gut microbial homeostasis. Due
to their special environment and function, these GCs require
specialized forms of regulation (139).
Peyer’s patches are non-encapsulated lymphoid tissues
associated with the small intestinal epithelium. In mice, 6–12 PPs
are interspersed along the whole length of the small intestine,
while the human intestine is associated with 100–200 PPs (139).
PPs are continuously exposed to antigenic stimulation by the
commensal microbiota. The intimate cross talk with the gut
microbiota is what sets PPs apart from other lymphoid tissues.
The gut microbiome is a complex mix of bacteria, fungi, viruses
and protozoa, which populates the whole intestine. Constant
stimulation through this microbiota drives the formation of
constitutively active GCs in PPs. These GCs produce antibodies
against infectious pathogens, but also generate commensal-
specific IgA antibodies that promote homeostasis of the gut
microbiome (140).
PPs as Places for TD IgA Production
PPs are an important site for T cell dependent IgA production
(139). Like other GCs, B cells within PP GCs undergo somatic
hypermutation of the Ig locus, followed by selection of B cells
bearing BCRs that bind antigen with high affinity. One key
difference to peripheral LNs, however, is that in PPs class-
switch recombination (CSR) to the IgA isotype occurs (141). IgA
antibodies exist as dimers and are secreted at all mucosal surfaces.
In the gut this is mediated by M cells in the sub-epithelial dome
of PPs. Once in the gut, IgAs bind to a wide variety of commensal
bacteria and alter the composition of the microbiome through
a variety of mechanisms (140). These include blocking antigen
interactions with the host, trapping antigens in the intestinal
mucus or interfering with invasive properties of pathogens
(140). In addition, IgA antibodies assist with the controlled
intestinal uptake of bacterial antigens to boost antigen-specific
gut immune response (142, 143). In AID-deficient animals that
lack CSR and SHM, there is aberrant expansion of anaerobic
gut commensals and extensive immune hyperplasia (144, 145).
Patients with selective IgA deficiency also exhibit changes in their
gut microbiome, associated with increased Th17-cell associated
inflammation (146). This demonstrates the key role that switched
antibody responses play in gut health.
What is not clear is whether this IgA needs to come from
the GC response. Evidence suggesting this is not the case
comes from studies in which mice lack either T-dependent
immune responses (CD28-deficient mice and CD40-deficient
mice) or Tfh cells (Bcl6flox/flox Cd4cre/+). These animals have
high IgA antibody titers, near-to-normal levels of bacterial IgA
coating, and relatively normal composition of the microbiota
(147–149). However, SHM of IgA antibodies mainly occurs
in GCs and analysis of mice that express a variant of AID
that can facilitate CSR, but not SHM, revealed that this
strain exhibited aberrant expansion of commensal bacteria and
increased bacterial translocation into mesenteric LNs (150). This
suggests that GC responses in the PP can play an important role
in the maintenance of microbial homeostasis.
Immune Regulation of GCs in PPs
Given the distinct architecture and location of PPs, their
regulatory mechanisms are unique from those in lymph node
GCs. Most importantly, Tfh and Tfr cells in PPs are responsive
to modulation by the gut microbiota. The ensuing plasticity in T
cell regulation allows PP GCs to respond adequately to intestinal
infections or changes in the gut microbiota.
Immune Regulation of PPs by Tfh Cells
PPs provide a unique environment for Tfh cell differentiation,
where the “rules” established for Tfh cell development are
frequently broken. Exclusively in the gut, Tfh cells can derive
from RORgt+ Th17 cells (151) and Foxp3+ Treg cells (152).
The precise mechanism for this is unclear, but it may be
driven by stimuli from the microbiota, as microbial sensing
plays an important role for Tfh differentiation in the gut. As
such, the Th17 cell-promoting segmented filamentous bacteria
(SFB) were shown to drive the differentiation of PP Tfh cells.
Further, microbial ATP controls Tfh cell differentiation in PPs
via interactions with the ATP-gated ionotropic P2X7 receptor
(153). The egress of these “unusual” PP Tfh cells into systemic
sites can have dire consequences for health, as they were reported
to exacerbate the auto-antibody responses in arthritis (154).
This demonstrates the ability of intestinal Tfh cells to integrate
multiple signals from the gut microbiota for their development,
with implications not only for gut, but also systemic immunity.
Therefore, control of Tfh cell development, and their maintained
residence in the gut is critical for organismal health.
Immune Regulation of PPs by Tfr
Similar to Tfh cells, PP Tfr cells have gut-specific features. In PP
GCs there is an increased Tfh/Tfr ratio compared to peripheral
GCs (155), making the PP resemble early stages of a GC. This has
been proposed to enable the expansion of low affinity B cell clones
early in the response (156). This is consistent with the proposal
of Reboldi et al. (139) who suggest that GCs in PPs resemble the
early stages of a GC in order to favor the quick generation of
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diverse low-affinity antibodies in response to microbial antigens.
Interestingly, gene expression profiling of Tfr cells from PPs and
pLNs revealed the surprising finding that PP Tfr cells express the
helper cytokine IL-4, unlike LN Tfr cells (157). This could point
to a different, potentially less suppressive, role of Tfr cells within
PPs.
As discussed above, Tfr cells are considered to be negative
regulators of the GC response, but the data about their
functionality in PPs is not clear. STAT3-KO mice, which lack
Tfr cells, but have PP Tfh cells, have no observable changes in
PP GC size or IgA production in the gut (117). However, in an
adoptive transfer model Kawamoto et al. implicated Tfr cells in
the regulation of IgA-mediated control of the gut microbiome:
Supplying T cell-deficient hosts with Treg cells increased IgA
production and induced dramatic changes in the composition
of the microbiota (125). This is consistent with the observation
that depletion of Treg cells results in a drop in IgA levels (158).
Together, this suggests that both Tfr functionality as well as the
Tfh/Tfr ratio in PPs are adjusted to allow for optimal control of
the gut microbiota, although further work is required to precisely
define the role for Tfr cells in PPs.
Regulation of PPs by the Microbiota
The gut microbiota is a crucial, but often underappreciated,
regulator of the GC response in the gut and the systemic
immune system. Germ-free mice, which lack any form of
bacterial colonization, exhibit evident deficits in the maturation
of their gut associated lymphoid tissues, including PPs and
mesenteric lymph nodes. Their PPs are small and produce
limited amounts of IgA antibodies (159). In addition, these mice
are more susceptible to enteric infections and their systemic
immune response to infections is also stunted (160, 161). This
demonstrates a strong dependency of the immune system on
the microbiota. There is evidence that some bacteria and their
products directly affect the GC response in PPs. Transfer of
a diverse microbiota into wild-type mice increases GC B cell
numbers as well as bacterial IgA-coating (125). Bacterial products
can also directly act on immune cells in the PP. Microbial ATP
controls Tfh cell differentiation (153) and short-chain fatty acids,
a diverse group of bacterial metabolites, were shown to boost
plasma cell differentiation and intestinal antibody production
in PPs (162, 163). This demonstrates the strong impact of the
microbiota on the GC response. Thus, the interplay of the
immune system with the microbiota cannot be neglected when
studying the regulation of intestinal GCs.
CONCLUSION
The importance of the GC response for humoral immunity
has been known for several decades. However, the cellular and
molecular mechanisms that regulate GC function are still being
elucidated. This review highlights several known mechanisms by
which GCs are regulated through the collaboration of multiple
cell types in both LNs and PPs. Given the participation of
GCs in physiological and pathological immune responses, a
better understanding of GC regulation is likely to have clinical
applications. In this respect, it is fundamental to consider and
further characterize the complex cellular network and interplay
that ultimately control the outcome of GC responses in specific
anatomic locations. Further elucidation of the mechanisms
which govern GC regulation will be beneficial to improve
patient stratification in immune-mediated diseases, and for the
identification of novel therapeutic biomarkers.
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